Golf, Fundraisers, and Pharma: Pfizer CEO's $25 Million Date With Trump

Pfizer CEO Albert Bourla attended a fundraiser for the pro-Trump super PAC MAGA Inc. at Trump's Bedminster golf club in early August 2025, an event aiming to raise about $25 million. The fundraiser came one day after Trump sent letters to Pfizer and 16 other pharmaceutical companies demanding they lower U.S. drug prices to match rates paid in other countries within 60 days.

The timing matters because it juxtaposed public pressure on drug pricing with a major industry executive's participation in a high-dollar fundraiser benefiting the president's political operation, feeding perceptions that access and political giving, not policy substance, drive outcomes in pharmaceutical regulation. Bourla has a history of engagement with the administration, including participating in the first Trump term's Operation Warp Speed and meeting with Trump before the second inauguration.

The episode illustrates a recurring tension in health policy: the administration's public rhetoric on drug prices has often been forceful but inconsistently followed through, while industry access to the president through fundraising and personal ties has remained constant.